SCHEMBL16305725

SCHEMBL16305725

CC(C)(C)c1ccc(-c2cnc(-c3ccc(C[C@H](NC(=O)c4ccc(C(C)(C)C)s4)C(=O)N4CC[C@H](C(=O)O)C4)cc3)nc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ F10 P00742 2/20 0.37
▸ TRPV1 Q8NER1 1/20 0.36
▸ ITGB3 P05106 2/20 0.36
▸ ITGA2B P08514 2/20 0.36
▸ ST14 Q9Y5Y6 2/20 0.36
▸ S1PR4 O95977 3/20 0.36
▸ S1PR1 P21453 3/20 0.36
▸ S1PR5 Q9H228 3/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ F2 P00734 1/20 0.35
▸ PLG P00747 1/20 0.35
▸ PLAU P00749 1/20 0.35
▸ MME P08473 1/20 0.35
▸ FPR2 P25090 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ ACKR3 P25106 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16306082 0.95 PRCP (0.42) PRCPKMT2AF10ST14F2
SCHEMBL16343137 0.94 ITGB3 (0.41) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL16295288 0.94 ITGB3 (0.41) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL16305700 0.94 S1PR4 (0.39) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL16342611 0.92 PRCP (0.37) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL17825459 0.92 PRCP (0.37) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL22150105 0.92 PRCP (0.37) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL16342612 0.92 PRCP (0.37) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL19485602 0.91 PRCP (0.38) PRCPKMT2AF10ITGB3ITGA2B
SCHEMBL17834406 0.91 S1PR5 (0.41) PRCPKMT2AF10ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008056-B1 NOVEL GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-12-09 — — EP disclosed
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
US-10259823-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2019-04-16 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2017-11-02 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-08-11 — — US disclosed
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-07-28 — — US disclosed
WO-2016094729-A1 GLP-1 RECEPTOR MODULATORS CELGENE INTERNATIONAL II SARL (CH) 2016-06-16 — — WO disclosed
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2015-01-08 — — US disclosed
WO-2014201172-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS, INC. (US) 2014-12-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885KMT2A 4232/4885F10 1321/4885
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885KMT2A 4232/4885F10 1321/4885
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885KMT2A 4232/4885F10 1321/4885
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885KMT2A 4232/4885F10 1321/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR PRCP 775/4885KMT2A 3867/4885F10 1183/4885
US-10259823-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR PRCP 775/4885KMT2A 3867/4885F10 1183/4885
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PRCP 600/4885KMT2A 4232/4885F10 1321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback